Lerner, Seth P <br/><br/>
Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer.  [electronic resource] 

 -  Urologic oncology   
 - 155-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1078-1439 
<br/><br/><label>Standard No.: </label>10.1016/j.urolonc.2007.11.033  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>BCG Vaccine--therapeutic use<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Immunotherapy--methods<br/>Male<br/>Middle Aged<br/>Neoplasm Invasiveness<br/>Prognosis<br/>Proportional Hazards Models<br/>Regression Analysis<br/>Risk<br/>Treatment Outcome<br/>Urinary Bladder Neoplasms--drug therapy